then FDA approval of psychedelics may be a matter of “when” not “if.” MAPS Executive Director Rick Doblin has been working to legalize MDMA for PTSD since the 1980's as ... [+] well as ...

The results showed that patients in the MDMA groups experienced a more significant reduction in PTSD symptom severity compared to those in the placebo groups. The FDA Advisory Committee expressed ...

The FDA has denied Lykos Therapeutics' marketing application for its post-traumatic stress disorder (PTSD) therapy based on MDMA, also known as ecstasy, in a setback for the emerging psychedelic ...

A medicine based on MDMA – the active ingredient in recreational drug ecstasy – is on the cusp of FDA approval as a treatment for post-traumatic stress disorder (PTSD), according to the ...

More than 70 percent of the MDMA group no longer qualified for a PTSD diagnosis, compared to 48 percent of the control group. The FDA's advisers worried that the negative effects of MDMA-assisted ...

A Boulder-based therapist said he's baffled and disappointed by federal regulators’ decision last month not to approve a therapy using MDMA ... for PTSD. Poulter said the FDA’s decision ...

The U.S. Food and Drug Administration (FDA) has issued a complete response letter for MDMA-assisted psychotherapy (MDMA-AT) for treating post-traumatic stress disorder (PTSD) in which it calls for ...

MDMA-assisted therapy ... time is a luxury that many patients with PTSD cannot afford. In recent years, the mental health industry has increasingly turned to FDA-cleared, neuroscience-based ...

FDA Rejects MDMA-AT for PTSD, but Lykos Vows to Push On Despite the FDA's rejection of MDMA-assisted therapy, Lykos Therapeutics plans to push ahead for approval, despite internal turmoil and ...

Brain damage that veterans suffered from flying shrapnel has provided a major clue that could lead to better treatment for ...